Indicators on Clinical trial recruitment for ABBV-744 study You Should Know
Participant eaten grapefruit or grapefruit products and solutions within three days just before the primary dose of study drug.- "Our study disclosed the crucial part in the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, for example OTX015 or ABBV-744, w